PE20142441A1 - Nueva dosificacion y formulacion - Google Patents
Nueva dosificacion y formulacionInfo
- Publication number
- PE20142441A1 PE20142441A1 PE2014002022A PE2014002022A PE20142441A1 PE 20142441 A1 PE20142441 A1 PE 20142441A1 PE 2014002022 A PE2014002022 A PE 2014002022A PE 2014002022 A PE2014002022 A PE 2014002022A PE 20142441 A1 PE20142441 A1 PE 20142441A1
- Authority
- PE
- Peru
- Prior art keywords
- aclidinium
- formulation
- lactose
- new dosage
- salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/0038—Cutting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
- A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
- A61M15/0051—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0086—Inhalation chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
- F04C2270/00—Control; Monitoring or safety arrangements
- F04C2270/04—Force
- F04C2270/042—Force radial
- F04C2270/0421—Controlled or regulated
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Referida a una composicion farmaceutica para la inhalacion que comprende aclidinio en forma de un polvo seco de una sal farmaceuticamente aceptable en mezcla con lactosa en polvo, donde la sal de aclidinio es bromuro de aclidinio, la razon en peso de aclidinio a lactosa es de 1:25 a 1:75 y el diametro medio de particula del aclidinio esta dentro del rango de 2 a 5 micrometros. Dicha composicion es util en el tratamiento de enfermedades respiratorias, particularmente, asma y enfermedad pulmonar obstructiva cronica (EPOC)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20120382211 EP2666465A1 (en) | 2012-05-25 | 2012-05-25 | Novel dosage and formulation |
US201261654224P | 2012-06-01 | 2012-06-01 | |
US201361779578P | 2013-03-13 | 2013-03-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20142441A1 true PE20142441A1 (es) | 2015-01-17 |
Family
ID=46210186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2014002022A PE20142441A1 (es) | 2012-05-25 | 2013-05-24 | Nueva dosificacion y formulacion |
Country Status (23)
Country | Link |
---|---|
US (2) | US20150118312A1 (es) |
EP (2) | EP2666465A1 (es) |
JP (1) | JP2015517560A (es) |
KR (1) | KR20150010757A (es) |
CN (1) | CN104349776A (es) |
AR (1) | AR091161A1 (es) |
AU (1) | AU2013265167B2 (es) |
CA (1) | CA2871357A1 (es) |
CL (1) | CL2014003211A1 (es) |
CO (1) | CO7200262A2 (es) |
CR (1) | CR20140536A (es) |
DO (1) | DOP2014000269A (es) |
EA (1) | EA201401309A1 (es) |
HK (1) | HK1203050A1 (es) |
IL (1) | IL235830A0 (es) |
IN (1) | IN2014DN08421A (es) |
MD (1) | MD20140131A2 (es) |
MX (1) | MX2014014041A (es) |
PE (1) | PE20142441A1 (es) |
PH (1) | PH12014502619A1 (es) |
SG (2) | SG11201407114YA (es) |
UY (1) | UY34829A (es) |
WO (1) | WO2013175013A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
CN104364785B (zh) * | 2012-06-01 | 2018-09-28 | 皇家飞利浦有限公司 | 用于为新生儿选择动脉血气测试的频率的方法和系统 |
CN105078932A (zh) * | 2015-09-06 | 2015-11-25 | 北京东方百泰生物科技有限公司 | 一种提高药物制剂中细粒子比例的方法及其制剂 |
CN107823193B (zh) * | 2017-11-16 | 2021-02-05 | 广州迈达康医药科技有限公司 | 一种阿地溴铵吸入型粉雾剂及其制备方法 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT7920688V0 (it) | 1979-02-05 | 1979-02-05 | Chiesi Paolo Parma | Inalatore per sostanze medicamentose pulverulente, con combinata funzione di dosatore. |
ATE23272T1 (de) | 1981-07-08 | 1986-11-15 | Draco Ab | Pulverinhalator. |
US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
FI69963C (fi) | 1984-10-04 | 1986-09-12 | Orion Yhtymae Oy | Doseringsanordning |
DE3927170A1 (de) | 1989-08-17 | 1991-02-21 | Boehringer Ingelheim Kg | Inhalator |
IT1237118B (it) | 1989-10-27 | 1993-05-18 | Miat Spa | Inalatore multidose per farmaci in polvere. |
US5201308A (en) | 1990-02-14 | 1993-04-13 | Newhouse Michael T | Powder inhaler |
GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
GB9015522D0 (en) | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
WO1992003175A1 (en) | 1990-08-11 | 1992-03-05 | Fisons Plc | Inhalation device |
DE4027391A1 (de) | 1990-08-30 | 1992-03-12 | Boehringer Ingelheim Kg | Treibgasfreies inhalationsgeraet |
DE69132850T2 (de) | 1990-09-26 | 2002-05-29 | Pharmachemie B.V., Haarlem | Wirbelkammer-Pulverinhalator |
GB9026025D0 (en) | 1990-11-29 | 1991-01-16 | Boehringer Ingelheim Kg | Inhalation device |
AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
DE4239402A1 (de) | 1992-11-24 | 1994-05-26 | Bayer Ag | Pulverinhalator |
US5829434A (en) | 1992-12-18 | 1998-11-03 | Schering Corporation | Inhaler for powdered medications |
PL182198B1 (en) | 1995-06-21 | 2001-11-30 | Asta Medica Ag | Pharmaceutic powder holding container with integrated measuring device and powdered |
ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
DE10129703A1 (de) | 2001-06-22 | 2003-01-02 | Sofotec Gmbh & Co Kg | Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren |
ITMI20010357U1 (it) | 2001-06-28 | 2002-12-30 | Plastiape Spa | Dispositivo inalatore |
DE10202940A1 (de) | 2002-01-24 | 2003-07-31 | Sofotec Gmbh & Co Kg | Patrone für einen Pulverinhalator |
ES2195785B1 (es) | 2002-05-16 | 2005-03-16 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
ES2211344B1 (es) | 2002-12-26 | 2005-10-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
PT1651270E (pt) * | 2003-07-29 | 2007-04-30 | Boehringer Ingelheim Int | Medicamentos para inalação compreendendo betamiméticos e um anticolinérgico |
ES2232306B1 (es) | 2003-11-10 | 2006-08-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
GB0410712D0 (en) | 2004-05-13 | 2004-06-16 | Novartis Ag | Organic compounds |
ES2251866B1 (es) | 2004-06-18 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
ES2251867B1 (es) | 2004-06-21 | 2007-06-16 | Laboratorios Almirall S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
KR101214823B1 (ko) | 2004-07-16 | 2012-12-24 | 알미랄, 에스.에이. | 분말 약제의 투약을 위한 흡입기 및 이 흡입기와 함께사용하기 위한 분말 카트리지 시스템 |
ES2298049B1 (es) * | 2006-07-21 | 2009-10-20 | Laboratorios Almirall S.A. | Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano. |
EP2100598A1 (en) * | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100599A1 (en) * | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
WO2011120779A1 (en) * | 2010-04-01 | 2011-10-06 | Chiesi Farmaceutici S.P.A. | Process for preparing carrier particles for dry powders for inhalation |
-
2012
- 2012-05-25 EP EP20120382211 patent/EP2666465A1/en not_active Withdrawn
-
2013
- 2013-05-24 CA CA2871357A patent/CA2871357A1/en not_active Abandoned
- 2013-05-24 KR KR1020147032690A patent/KR20150010757A/ko not_active Application Discontinuation
- 2013-05-24 SG SG11201407114YA patent/SG11201407114YA/en unknown
- 2013-05-24 AU AU2013265167A patent/AU2013265167B2/en not_active Ceased
- 2013-05-24 SG SG10201609244PA patent/SG10201609244PA/en unknown
- 2013-05-24 UY UY34829A patent/UY34829A/es not_active Application Discontinuation
- 2013-05-24 CN CN201380027441.4A patent/CN104349776A/zh active Pending
- 2013-05-24 EP EP13725154.2A patent/EP2854808A1/en not_active Withdrawn
- 2013-05-24 IN IN8421DEN2014 patent/IN2014DN08421A/en unknown
- 2013-05-24 PE PE2014002022A patent/PE20142441A1/es not_active Application Discontinuation
- 2013-05-24 MX MX2014014041A patent/MX2014014041A/es unknown
- 2013-05-24 WO PCT/EP2013/060808 patent/WO2013175013A1/en active Application Filing
- 2013-05-24 JP JP2015513219A patent/JP2015517560A/ja active Pending
- 2013-05-24 EA EA201401309A patent/EA201401309A1/ru unknown
- 2013-05-24 MD MDA20140131A patent/MD20140131A2/ro not_active Application Discontinuation
- 2013-05-24 US US14/403,220 patent/US20150118312A1/en not_active Abandoned
- 2013-05-24 AR ARP130101828 patent/AR091161A1/es unknown
-
2014
- 2014-11-20 IL IL235830A patent/IL235830A0/en unknown
- 2014-11-21 CR CR20140536A patent/CR20140536A/es unknown
- 2014-11-24 CO CO14258287A patent/CO7200262A2/es unknown
- 2014-11-24 PH PH12014502619A patent/PH12014502619A1/en unknown
- 2014-11-25 CL CL2014003211A patent/CL2014003211A1/es unknown
- 2014-11-25 DO DO2014000269A patent/DOP2014000269A/es unknown
-
2015
- 2015-04-13 HK HK15103573.2A patent/HK1203050A1/xx unknown
-
2017
- 2017-01-19 US US15/409,741 patent/US20170128426A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CR20140536A (es) | 2014-12-15 |
EP2666465A1 (en) | 2013-11-27 |
SG11201407114YA (en) | 2014-12-30 |
CA2871357A1 (en) | 2013-11-28 |
US20150118312A1 (en) | 2015-04-30 |
AR091161A1 (es) | 2015-01-14 |
AU2013265167A1 (en) | 2014-10-30 |
JP2015517560A (ja) | 2015-06-22 |
DOP2014000269A (es) | 2015-02-27 |
HK1203050A1 (en) | 2015-10-16 |
CL2014003211A1 (es) | 2015-06-05 |
EP2854808A1 (en) | 2015-04-08 |
CN104349776A (zh) | 2015-02-11 |
MX2014014041A (es) | 2015-02-12 |
UY34829A (es) | 2013-12-31 |
IL235830A0 (en) | 2015-01-29 |
IN2014DN08421A (es) | 2015-05-08 |
EA201401309A1 (ru) | 2015-06-30 |
KR20150010757A (ko) | 2015-01-28 |
CO7200262A2 (es) | 2015-02-27 |
SG10201609244PA (en) | 2016-12-29 |
PH12014502619A1 (en) | 2015-01-21 |
WO2013175013A1 (en) | 2013-11-28 |
AU2013265167B2 (en) | 2017-08-17 |
US20170128426A1 (en) | 2017-05-11 |
MD20140131A2 (ro) | 2015-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20142441A1 (es) | Nueva dosificacion y formulacion | |
CL2009000601A1 (es) | Composicion farmaceutica inhalable en forma de polvo seco que comprende bromuro de aclidinio y un vehiculo, que proporciona una dosis nominal medida de aclinio equivalente a aproximadamente 200 ug de bromuro de aclinio; su uso en epoc y asma; dispositivo inhalador de polvo seco multidosis. | |
PE20190406A1 (es) | Composiciones farmaceuticas que comprenden bromuro de aclidinio | |
ES2539612T3 (es) | Formulaciones de partículas en polvo seco que contienen dos o más principios activos para el tratamiento de las enfermedades obstructivas o inflamatorias de las vías respiratorias | |
CL2016000735A1 (es) | Inhalador de polvo seco que comprende una composición farmacéutica inhalable que comprende propionato de fluticasona, xinafoato de salmeterol y un vehículo de lactosa; uso para tratar asma o epoc. | |
PE20150171A1 (es) | Nueva forma de dosificacion y formulacion de abediterol | |
EA201590030A1 (ru) | Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы, и третий компонент | |
EA201590019A1 (ru) | Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы | |
BR112015027017A2 (pt) | composições farmacêuticas inaláveis e dispositivos inaladores que contêm as mesmas | |
EA201201397A1 (ru) | Ингалятор, содержащий расслаиваемую блистерную упаковку | |
EA201201395A1 (ru) | Кнопочное устройство мундштука ингалятора сухого порошка | |
EA201201391A1 (ru) | Ингалятор | |
EA201201392A1 (ru) | Кнопочное устройство мундштука ингалятора сухого порошка | |
EA201201393A1 (ru) | Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка | |
EA201590036A1 (ru) | Композиции для ингалятора сухого порошка, содержащие антагонисты мускариновых рецепторов длительного действия | |
EA201201389A1 (ru) | Ингалятор, создающий турбулентность | |
EA201591871A1 (ru) | Фармацевтическая композиция, содержащая будесонид и формотерол | |
EA201201394A1 (ru) | Ингалятор для доставки лекарственного средства в виде сухого порошка | |
TR200909788A2 (tr) | Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu | |
EA201700183A1 (ru) | Лекарственный препарат, содержащий будесонид и формотерол | |
BR112014028864A2 (pt) | dosagem e formulação | |
AR098867A1 (es) | Composición farmacéutica en polvo seco para inhalación | |
TR201004317A2 (tr) | Türbülans oluşumunu sağlayan inhalasyon cihazı. | |
TH147031A (th) | ขนาดการให้ยาและสูตรผสมชนิดใหม่ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |